This test is available at Molecular Diagnostics and Therapy. It identifies IgG anti-phospholipid antibodies in the blood. These may increase the risk of abnormal clotting and complications during pregnancy. The test can be used in conjunction with clinical symptoms and further investigations to help a doctor make a diagnosis of anti-phospholipid syndrome (APS).
The Anti-Phospholipid Antibodies (IgG) test identifies IgG antibodies associated with anti-phospholipid syndrome. Depending on the method and specification of this test, this may include anticardiolipin IgG antibodies. This test helps to identify an anti-phospholipid antibody that may be increasing the risk of abnormal clotting and complications in pregnancy.
This test is often requested as part of a panel of tests to detect anti-phospholipid antibodies. This may include anticardiolipin IgM, anti-beta-2 glycoprotein I, and lupus anticoagulant. A positive result must be interpreted in the context of clinical symptoms. To confirm persistent positive anti-phospholipid antibodies, this test is typically repeated at least 12 weeks after initial testing, if clinically indicated.
APS is an autoimmune disease that increases the risk of venous and arterial clotting. It can also cause complications during pregnancy. IgG anti-phospholipid antibodies are an important marker in diagnosing this condition. A diagnosis of anti-phospholipid syndrome requires appropriate clinical symptoms and laboratory results.
Anti-phospholipid antibodies can be associated with venous clotting. This can include deep vein thrombosis (DVT) and pulmonary embolism. This test may be used to help investigate whether an underlying risk of venous clotting due to anti-phospholipid antibodies may be present.
APS may lead to arterial clotting, which may cause complications such as stroke and other circulatory problems. This test may be requested as part of the investigation of suspected anti-phospholipid syndrome.
Anti-phospholipid antibodies are associated with recurrent miscarriage and other adverse outcomes in pregnancy. This test may be used to help determine whether anti-phospholipid antibodies are present in patients as part of further investigations.
Anti-phospholipid antibodies may be present in patients with autoimmune diseases such as SLE. If symptoms, patient history, or previous laboratory investigations suggest that an individual may have a condition related to anti-phospholipid antibodies, this test may be requested.
Molecular Diagnostics and Therapy provides integrated diagnostic services including Radiology, Nuclear Medicine and Pathology. We ensure accurate diagnostic testing with careful sample handling, standardised methods, expert analysis and quality control. We provide clear and reliable results in a patient-centred way.
If you would like to take this test, contact Molecular Diagnostics and Therapy. Please bring a prescription from your doctor and any relevant clinical information and previous reports. Usually, this test does not require fasting. However, please follow any specific instructions given by your doctor or diagnostic lab. If you are taking anticoagulant medication, please inform your doctor. If further testing for lupus anticoagulant will be carried out, it is particularly important to let your doctor know.
Test information: Fasting is generally not required.
Reporting: Within 24 hours*